Koyfin Home > Directory > Health Care > Abbott Laboratories > EV / EBITDA (ntm)

Abbott Laboratories EV / EBITDA (ntm) Chart (ABT)

Abbott Laboratories annual/quarterly EV / EBITDA (ntm) from 2010 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Abbott Laboratories EV / EBITDA (ntm) for the quarter ending December 12, 2020 was 18.62 a 1.79% increase of 0.33 year over year
  • Abbott Laboratories EV / EBITDA (ntm) for the last 12 months ending December 12, 2020 was 18.62 a 1.79% increase of 0.33 year over year
  • Abbott Laboratories Annual EV / EBITDA (ntm) for 2020 was 18.62 a 0.23% increase of 0.04 from 2019
  • Abbott Laboratories Annual EV / EBITDA (ntm) for 2020 was 18.58 a 0.52% increase of 0.10 from 2019
  • Abbott Laboratories Annual EV / EBITDA (ntm) for 2020 was 18.48 a 1.05% increase of 0.19 from 2019
Other Valuation Metrics:
  • Abbott Laboratories Market Cap for the quarter ending June 06, 2018 was $106,927m a 13.30% increase of 14,217m year over year
  • Abbott Laboratories Price / Book for the quarter ending June 06, 2018 was 3.41 a 13.85% increase of 0.47 year over year
  • Abbott Laboratories Enterprise Value for the quarter ending June 06, 2018 was $125,177m a 14.40% increase of 18,026m year over year
View Chart On Koyfin

Quarterly ABT EV / EBITDA (ntm) Data

12/202018.62
11/202018.58
11/202018.48
11/202018.29
11/202018.48
11/202018.75
11/202019.01
11/202019.02
11/202018.83
11/202019.35

Annual ABT EV / EBITDA (ntm) Data

202018.62
202018.58
202018.48
202018.29
202018.48
202018.75
202019.01
202019.02
202018.83
202019.35